3Sonja Wolfahrt,Bernhard Kleine,Hubertus Jarry,et al.Endogenous regulation of the GnRH receptor by GnRH in the human placenta[J].Molecular Human Reproduction.2001,7(1):89-95.
4Jennifer M,Mulvaney.Divergent signaling pathways requiring discrete calcium signals mediate concurrent activation of two mitogen-activated protein kinases by gonadotropin releasing hormone[J].The Journal of Biological Chemistry.2000,275(19):14182-14189.
6Rafael Vazquez Martinez,Spencer L Shorte,William J Faught,et al.Pulsatile exocytosis is functionally associated with GnRH gene expression in immortalized GnRH expressing cells[J].Endocrinology,2001,142(12):5364-5370.
7Gregoy Y Bédécarrats,Ursula B Kaiser.Differential regula tion of gonadotropin subunit gene promoter activity by pulsatile gonadotropin-releasing hormone (GnRH) in perifused LβT2 cells:role of GnRH receptor concentration[J].Endocrinology.2003,144(5):1802-1811.
9Alon Chen,Ella Kaganovsky,Shai Rahimipour,et al.Two Forms of Gonadotropin-releasing Hormone (GnRH) Are Expressed in Human Breast Tissue and Overexpressed in Breast Cancer[J].Cancer Research.2002,62(2):1036-1044.
10Astrid Chamson Reig,Eleonora M.Sorianello,Paolo N.Catalano,et al.Gonadotropin-releasing hormon signaling pathways in an experimental Ovarian tumor[J].Endocrinology.2003,144(7):2957-2966.
2[1]Albano C, Smitz J, Camus M, et al. Comparison of different of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation. Fertil Steril,1997,67:917-922.
3[2]Albano C, Grimbizis G, Smitz J, et al. The luteal phase of nonsupplemented cycles after ovarian superovulation with human menopausal gonadotropin and the gonadotropin-releasing hormone antagonist Cetrorelix. Fertil Steril,1998,70:357-359.
4[3]Felverbaum R, Diedrich K. Ovarian stimulation in ART: use of GnRH-antagonists. Fertil Reprod Med. Proceedings of the XVI World Congress on Fertility and Sterility, San Francisco,1998.113-124.
5[4]Olivennes F, Alvarez S, Bouchard P, et al. The use of GnRH antagonist (Cetrorelix) in a single dose protocol in IVF-embryo transfer: a dose finding study of 3 versus 2 mg. Hum Reprod,1998,13:2411-2414.
6[5]Michael CP, Crowley WF. Gonadotropin-releasing hormone and its analoges. Annu Rev Med,1994,45:391-405.
7[6]Rivier JE, Poter J, Rivier CL, et al. new effective gonadotropin releasing hormone antagonist with minimal potency for histamine release in vitro. J Med Chem,1986,29:1846-1851.
8[7]Marshall LA, Fluker MR, Jaffe RB, et al. Inhibition of follicular development by a potent antagonist analog of gonadotropin-releasing hormone(Detirelix). J Clin Endocrinol Metab,1991,72:933-937.
9[8]Frydman R, Taieb J, Cornel C, et al. Prevention of premature luteinizing hormone and progesterone rise with a gonadotropin-releasing hormone antagonist, Nal-Glu, in controlled ovarian hyperstimulation, Fertil Steril,1991,56:923-928.
10[9]Olivennnes F, Taieb J, Fanchin R, et al. The single or dual administration of the gonadotropin-releasing hormone antagonist Cetrorelix in an in vitro fertilization-embryo transfer program. Fertil Steril,1994,62:468-476.
